Supreme Court Backs Newly Drawn Texas House Electoral Boundaries.
-
- By Scott Best
- 14 May 2026
Acclaimed soul vocalist D’Angelo died on October 14 at age 51 after a personal fight with pancreatic malignancy.
“The shining star of our household has faded away for us in the present world,” his family confirmed. “After a prolonged and courageous battle with cancer, we are deeply saddened to announce that D’Angelo, known to his fans around the globe as D’Angelo, has been called home.”
D’Angelo made a lasting impact on music with his innovative neo-soul sound and partnerships with renowned musicians.
He launched his debut album, “Brown Sugar,” in the mid-nineties to instant praise. The record achieved No. 4 on Billboard’s Top R&B Albums chart, earned platinum status later that year, and received several award nominations.
However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his music career into the stratosphere. The album premiered at No. 1 on each of Billboard’s Top R&B Albums chart and the main album chart. He received two Grammy Awards: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”
The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal showed the artist, notably stripped down to his midsection, singing directly into the camera.
D’Angelo stepped back from the spotlight after putting out Voodoo and publicly struggled with substance abuse. In 2005, he was part of a severe car crash that put him in grave health.
Over ten years later, his third and final album, “Black Messiah” (2014), reaffirmed his lasting popularity with a further No. 1 debut on the soul music rankings and a award for Best R&B Album.
Once more, in his own enigmatic fashion, D’Angelo made only a few public outings in the subsequent period.
The musician was scheduled as a headliner for the 2025 music event, but his appearance was called off, citing an “unforeseen medical delay.”
Even though information is limited about D’Angelo’s well-being in the months leading up to his passing, he had reportedly been hospitalized for months and in palliative care for two weeks.
D’Angelo’s demise is a stark reminder of the devastating effects of pancreatic cancer, one of the most deadly and hardest to prevent forms of the illness, on a gifted artist whose life was cut short.
“We are saddened that he can only provide dear memories with his loved ones, but we are forever thankful for the legacy of extraordinarily moving songs he has left us,” his kin said.
Pancreatic malignancy impacts the pancreas, a small organ that produces the hormone insulin and plays an essential role in digestion, among other functions. The position and dimensions of the pancreas in the human system make it more difficult to detect malignancy.
Even though this cancer makes up only approximately three percent of cancer diagnoses each year in the U.S., it is responsible for seven percent of cancer deaths.
Nearly 70,000 individuals will be diagnosed with this condition and roughly 52,000 will die of the disease in 2025.
“Pancreatic cancer is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have few and poor treatment options, and a narrow opportunity to make a meaningful impact on the lives of patients,” noted a cancer specialist.
Because pancreatic cancer rarely causes early symptoms, it’s frequently identified only once the disease is advanced. Although a individual has indicators they are often nonspecific and may be mistaken for a number of common illnesses.
“As of yet, there is no good way to identify this malignancy in the early stages, except for listening to your body and speaking with your physician if there are new or unusual symptoms,” explained a medical director.
Frequent indicators of this disease include:
At 51 years old, D’Angelo’s demise is an outlier, as this malignancy is most common in adults in the 65 to 75 age bracket. However, many cancers, including this type, have become increasingly prevalent among younger people.
“Pancreatic cancer identified prior to fifty is deemed rare, yet concerningly, doctors are beginning to see a growing number of younger individuals affected by this disease,” commented a specialist.
In the absence of reliable detection methods for pancreatic cancer, experts emphasized the importance of understanding your relatives’ cancer history. Some risk factors, such as smoking and obesity also have an influence in the development of this disease.
Black individuals have the highest incidence of pancreatic cancer in the U.S. and are most likely to be found to have untreatable disease.
“The initial action toward reducing one’s chance of this condition is understanding individual susceptibility. People should examine their family history, genetic background, and health issues, such as blood sugar disease, chronic pancreatitis, or obesity that may increase their susceptibility,” advised a specialist.
Hereditary risk factors are linked to as much as 10% of all this malignancy cases. If a relative in your family has had this disease, you may want to consider genetic testing.
“For individuals with a family history of pancreatic cancer or those carrying high risk genetic mutations, checking may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to find initial alterations in the organ,” he clarified.
For those wishing to lower their chance, lifestyle changes may have an effect. The best action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, stay away altogether.
Heavy alcohol consumption is associated with pancreas inflammation, a risk factor for pancreatic cancer, so reducing or abstaining from drinks may help lower your chance.
Controlling your weight or losing weight may also aid reduce your risk. Individuals with excess weight are twenty percent more prone to develop this disease. This malignancy also occurs more often in people with diabetes, and weight loss can also lower the chance of type 2 diabetes.
In spite of pancreatic cancer’s poor prognosis, there is reason for optimism.
“We are doing better with therapies and newer mixed drug treatments. There are developing precision medicines that are already making an impact,” said a expert.
For numerous individuals, however, education about this rare but {dev
A geospatial analyst with over a decade of experience in terrain modeling and environmental data visualization.